Related Experiment Video

Updated: Jun 1, 2026

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies
08:54

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies

Published on: February 17, 2023

Anticancer prodrugs: an overview of major strategies and recent developments

Silvia Arpicco1, Franco Dosio, Barbara Stella

  • 1Universita degli Studi di Torino, Facolta di Farmacia, Dipartimento di Scienza e Tecnologia del Farmaco, Via P. Giuria 9, 10125 Torino, Italy. silvia.arpicco@unito.it

Current Topics in Medicinal Chemistry
|June 16, 2011
PubMed

Insights

Prodrugs offer a promising strategy to improve anticancer chemotherapy by enhancing tumor selectivity and reducing systemic toxicity. This approach converts inactive compounds into active drugs within the body, improving treatment efficacy.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Oncology

Background:

  • Anticancer chemotherapy has improved survival rates but faces challenges with narrow therapeutic windows due to systemic toxicity and lack of tumor selectivity.
  • Current drug development often involves creating new analogues or prodrugs to overcome these limitations.

Purpose of the Study:

  • To review prodrug development strategies for anticancer agents.
  • To illustrate the chemical implementation of prodrug approaches with selected drug candidates.

Main Methods:

  • Literature review of prodrug strategies in anticancer chemotherapy.
  • Categorization of prodrug approaches based on principal anticancer agent types.
  • Analysis of chemical implementation in selected prodrug candidates.

Main Results:

  • Prodrugs are inactive compounds metabolized to active drugs, offering improved tumor selectivity and reduced toxicity.
  • Various prodrug strategies have been developed across different categories of anticancer agents.
  • Chemical implementation of prodrugs demonstrates feasibility and potential for clinical application.

Conclusions:

  • Prodrug development is a key medicinal chemistry strategy to enhance the therapeutic index of anticancer drugs.
  • Targeted delivery and controlled release via prodrugs can mitigate systemic toxicity and improve treatment outcomes.
  • Further research and development in prodrug design hold significant promise for advancing cancer chemotherapy.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Related Concept Videos

Prodrugs01:30

Prodrugs

Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...